+919405117673

Diabetology Medicine & Weight Loss

Sembolic 15mg/3ml KwikPen – Semaglutide Injection

In stock

Description

Sembolic 15mg/3ml is a semaglutide injection developed for use in adults with type 2 diabetes and for chronic weight management, as prescribed by a qualified healthcare professional. Sembolic is marketed by Torrent Pharmaceuticals, with the 15 mg/3 mL formulation supplied as a prefilled cartridge designed for use with a reusable pen device.

Sembolic 15mg/3ml Product Information

Sembolic contains semaglutide, a GLP-1 receptor agonist. The 15 mg/3 mL cartridge provides semaglutide for dose administration through the compatible reusable pen system. The formulation is designed to provide different prescribed doses from a single cartridge, allowing treatment to be adjusted according to the patient's medical needs.

For people with type 2 diabetes, semaglutide is used alongside diet and physical activity to help improve glycemic control. Semaglutide is also indicated in appropriate adults for chronic weight management together with a reduced-calorie diet and increased physical activity. Treatment should be selected and monitored by a healthcare professional.

How Does Sembolic Work?

Semaglutide acts on GLP-1 receptors involved in blood-glucose regulation and appetite control. It can enhance glucose-dependent insulin secretion, reduce glucagon secretion when glucose is elevated, and slow gastric emptying. These effects contribute to improved blood-sugar management and can support weight-management treatment when clinically appropriate.

Sembolic 15mg/3ml Administration

Sembolic is administered by subcutaneous injection, generally once weekly according to the prescribed treatment schedule. The injection may be administered in areas such as the abdomen, thigh, or upper arm. The appropriate starting dose and dose-escalation schedule depend on the indication and individual clinical circumstances. Patients should follow the prescribing information and their healthcare professional's instructions rather than changing the dose themselves.

Safety Information

Common adverse effects reported with semaglutide include nausea, vomiting, diarrhoea, abdominal pain and constipation. Other clinically important risks can occur, including pancreatitis, gallbladder-related problems, allergic reactions and certain eye complications. Patients should review the complete prescribing information before treatment.

Sembolic is a prescription medicine. It should only be supplied and used in accordance with applicable medical and pharmaceutical regulations.

Sembolic 15mg/3ml Supply from India

Global Pharma Trade provides pharmaceutical sourcing and export support from India for eligible international buyers. For Sembolic 15mg/3ml requirements, buyers can contact the team to discuss product availability, pack details, documentation, shipping requirements and applicable export regulations.

Product: Sembolic 15mg/3ml

Active ingredient: Semaglutide

Dosage form: Injection / prefilled cartridge with reusable pen system

Prescription status: Prescription medicine

Keywords